The following table shows the list of Horizon 2020 projects developed by "GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | anTBiotic | H2020-EU.3.1.3. | coordinator | 1˙923˙768.00 | 2017-01-01 | 939 |
2 | LYMPHVECs | H2020-EU.1.3.2. | coordinator | 158˙121.00 | 2019-03-01 | 271 |
3 | TRIC-TB | H2020-EU.3.1.7. | participant | 0.00 | 2019-05-01 | 285 |
4 | ERA4TB | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 399 |
totale | 2˙081˙889.00 |
This organization collaborated with partners in 15 countries.
Within the project anTBiotic this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | ZA | TASK | TASK FOUNDATION NPC (OTH) |
participant | DE | FZB | FORSCHUNGSZENTRUM BORSTEL (REC) |
participant | ZA | UCT | UNIVERSITY OF CAPE TOWN (HES) |
participant | NO | UiT | UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET (HES) |
Within the project LYMPHVECs this organization got in touch with:
Only 1 participant
Within the project TRIC-TB this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
coordinator | CH | BioVersys | BIOVERSYS AG (PRC) |
Within the project ERA4TB this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | BMGF | BILL & MELINDA GATES FOUNDATION (REC) |
participant | IE | C-Path | CRITICAL PATH INSTITUTE, LIMITED (PRC) |
participant | BE | SCI | SCIENSANO (REC) |
participant | NL | QPS | QPS NETHERLANDS BV (PRC) |
participant | CH | iM4TB | FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB) (OTH) |
participant | DK | GRIT | GRITSYSTEMS AS (PRC) |
participant | FR | Bioaster | BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE (REC) |
participant | FR | IBT | IMABIOTECH SAS (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | DH | Department of Health (REC) |
participant | US | TBA | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION (REC) |
participant | DE | EVT | EVOTEC INTERNATIONAL GMBH (PRC) |
participant | BE | Janssen | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | SERMAS | SERVICIO MADRILENO DE SALUD (PUB) |
participant | FR | IPL | INSTITUT PASTEUR DE LILLE FONDATION (REC) |
participant | DE | FZB | FORSCHUNGSZENTRUM BORSTEL (REC) |
participant | LV | IOS | LATVIJAS ORGANISKAS SINTEZES INSTITUTS (REC) |
participant | DE | UHC | KLINIKUM DER UNIVERSITAET ZU KOELN (HES) |
participant | IT | UPV | UNIVERSITA DEGLI STUDI DI PAVIA (HES) |
participant | ES | UNIZAR | UNIVERSIDAD DE ZARAGOZA (HES) |
coordinator | ES | UC3M | UNIVERSIDAD CARLOS III DE MADRID (HES) |
participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
participant | CH | EPFL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (HES) |
participant | UK | UD | UNIVERSITY OF DUNDEE (HES) |
participant | IT | CNR | CONSIGLIO NAZIONALE DELLE RICERCHE (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
participant | FR | IP | INSTITUT PASTEUR (REC) |
participant | IT | UNIPD | UNIVERSITA DEGLI STUDI DI PADOVA (HES) |